Lv1
40 积分 2024-09-25 加入
Senti-202, a Selective, Off-the-Shelf, Preclinical CAR-NK Cell Therapy with CD33 and/or FLT3 Activating CAR, Healthy Cell Protection from Endomucin (EMCN) Inhibitory CAR and Calibrated Release IL-15 for Hematologic Malignancies Including AML
6小时前
已完结
靶向CD7的嵌合抗原受体NK-92MI细胞对CD7阳性血液系统恶性肿瘤细胞的杀伤作用
2个月前
已完结
Large-scale generation of iNK and CAR-iNK cells from CD34 haematopoietic stem and progenitor cells for adoptive immunotherapy+
2个月前
已完结
CAR-NK cells for haematological cancers
2个月前
已完结
皖公网安备34019202002308
